Prognostic implication of SOX2 expression in small intestinal adenocarcinoma
Authors:
Preprint
- 31 March 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: The presence of KRAS mutation enhance the stem cell features of colorectal carcinoma cells containing mutant adenomatous polyposis coli (APC). However, their potential role in small intestinal adenocarcinoma remains elusive. Here, we aimed to investigate the clinical significance of cancer stem cell markers in the context of small intestinal adenocarcinoma with the KRAS genotype. Methods: SOX2, NANOG, and OCT4 expression were assessed by immunohistochemistry and digital image analysis, and their potential association with KRAS was further examined in 185 small intestinal adenocarcinoma patients. Results: Positive expression of SOX2, NANOG, and OCT4 was detected in 65 (35.1%), 94 (50.8%), and 82 (44.3%) of patients, respectively. SOX2-/wild-type KRAS (KRASWT) was often observed in low-grade carcinoma (P = 0.048). SOX2+ and SOX2+/mutant KRAS (KRASMT) were significantly associated with shorter overall survival relative to SOX2- and others (P < 0.001, both). Multivariate analysis revealed SOX2+ (HR=1.929 [95% CI, 1.320-2.819], P = 0.001) as an independent prognostic factor of worse overall survival among small intestinal adenocarcinoma patients. Conclusions: These results suggest that SOX2 expression, in conjunction with KRAS, is a potential prognostic marker for small intestinal adenocarcinoma.Keywords
All Related Versions
- Version 1, 2020-03-31, Research Square
- Published version: Virchows Archiv, 478 (6), 1049.
This publication has 28 references indexed in Scilit:
- Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical SuccessStem Cells Translational Medicine, 2018
- Genomic Profiling of Small-Bowel AdenocarcinomaJAMA Oncology, 2017
- Advances in cancer stem cell targeting: How to strike the evil at its rootAdvanced Drug Delivery Reviews, 2017
- Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: Effects associated with STAT3/SurvivinCancer Letters, 2013
- Nanog: A Potential Biomarker for Liver Metastasis of Colorectal CancerDigestive Diseases and Sciences, 2012
- Wnt: What's Needed To maintain pluripotency?Nature Cell Biology, 2011
- A single-institution experience with 491 cases of small bowel adenocarcinomaThe American Journal of Surgery, 2010
- Concise Review: Isoforms of OCT4 Contribute to the Confusing Diversity in Stem Cell BiologyStem Cells, 2010
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Prognostic Factors of Primary Small Bowel Adenocarcinoma: Univariate and Multivariate AnalysisWorld Journal of Surgery, 2006